Stock Price Quote

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE3104.95-85.65 (-2.68 %)
PREV CLOSE ( ) 3190.60
OPEN PRICE ( ) 3188.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1681
TODAY'S LOW / HIGH ( )3085.20 3188.25
52 WK LOW / HIGH ( )2488 3589.95
NSE3106.50-86.4 (-2.71 %)
PREV CLOSE( ) 3192.90
OPEN PRICE ( ) 3200.00
BID PRICE (QTY) 3106.50 (103)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 212638
TODAY'S LOW / HIGH( ) 3082.00 3235.85
52 WK LOW / HIGH ( )2487.8 3590.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1972
Management Info
Samir Mehta - Chairman - Managing Director
Registered Office

Address Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

24Jan Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that the Board has at its meeting h..
27Dec Torrent Pharmaceuticals raises Rs 200
Torrent Pharmaceuticals has raised Rs 200 crore through Commercial Paper..
05Dec Torrent Pharma enters into agreement w
Torrent Pharmaceuticals has entered into an agreement to acquire brands..
05Dec Torrent Pharma rises on entering into
Torrent Pharmaceuticals is currently trading at Rs. 3364.30, up by 14.70..
27Sep Torrent Pharmaceuticals incorporates W
Torrent Pharmaceuticals has incorporated Wholly owned subsidiary (WOS) n..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit485013570
Gross Profit 6510 19170
Operating Profit 890029810
Net Sales 2377085330

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  5949.15 (0.31%)
M.Cap ( in Cr)157931.24
Everest Organics (BSE)
peergroup  270.00 (1.96%)
M.Cap ( in Cr)262.18
Shukra Pharma (BSE)
peergroup  219.50 (1.95%)
M.Cap ( in Cr)961.15
Panchsheel Organics (BSE)
peergroup  198.75 (1.71%)
M.Cap ( in Cr)261.79
Medico Remedies (BSE)
peergroup  69.97 (2.09%)
M.Cap ( in Cr)580.64

Shareholding Pattern

NON-INSTITUTION 7.17%
PROMOTERS 68.31%
MUTUAL FUNDS/UTI 4.88%
FI/BANKS/INSURANCE 1.7%
GOVERNMENT 0%
FII 0%

About Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd. was incorporated in the year 1972. Its today's share price is 3104.95. Its current market capitalisation stands at Rs 105085.62 Cr. In the latest quarter, company has reported Gross Sales of Rs. 87079.5 Cr and Total Income of Rs.86243.9 Cr. The company's management includes Pranav Mehta, Chintan Trivedi, Jinal Mehta, Aman Mehta, Jinesh Shah, Nikhil Khattau, Manish Choksi, Maurice Chagnaud, Nayantara Bali, Ameera Shah, Samir Mehta.

It is listed on the BSE with a BSE Code of 500420 , NSE with an NSE Symbol of TORNTPHARM and ISIN of INE685A01028. It's Registered office is at Torrent House,Off Ashram Road,Ahmedabad-380009, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, CC Chokshi & Co, Deloite Haskins & Sells, Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.